Homeopathic Individualized Q-Potencies versus Fluoxetine for Moderate to Severe Depression: Double-Blind, Randomized Non-Inferiority Trial
2011

Homeopathy vs. Fluoxetine for Depression

Sample size: 91 publication Evidence: moderate

Author Information

Author(s): U. C. Adler, N. M. P. Paiva, A. T. Cesar, M. S. Adler, A. Molina, A. E. Padula, H. M. Calil

Primary Institution: Faculdade de Medicina de Jundiaí, Universidade Federal de São Paulo

Hypothesis

The study aims to investigate the non-inferiority and tolerability of individualized homeopathic medicines compared to fluoxetine in treating acute depression.

Conclusion

The study indicates that individualized homeopathic Q-potencies are not inferior to fluoxetine in treating moderate to severe depression.

Supporting Evidence

  • Mean MADRS scores differences were not significant at the 4th and 8th weeks of treatment.
  • Response rates were similar between homeopathy and fluoxetine groups at both the 4th and 8th weeks.
  • Tolerability showed no significant differences, although fluoxetine had a higher percentage of troublesome side effects.

Takeaway

This study tested if homeopathic treatments are as good as a common depression medicine called fluoxetine, and it found they work similarly.

Methodology

A double-blind, randomized, non-inferiority trial comparing individualized homeopathic Q-potencies to fluoxetine over 8 weeks.

Potential Biases

The study depended on a single homeopathic practitioner, which may introduce bias.

Limitations

The study had a small sample size, was conducted at a single center, and lacked a placebo control group.

Participant Demographics

The majority of participants were female (98%), with a mean age of approximately 42 years.

Statistical Information

Confidence Interval

95% CI −6.95, 0.86 at 4 weeks; 95% CI −6.05, 0.77 at 8 weeks

Digital Object Identifier (DOI)

10.1093/ecam/nep114

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication